We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Valuation
Financials (FY2024)
Investment Thesis
Buy Right Impex Limited is a 1983-incorporated Delhi company with a share price of ₹0.05, indicating likely dormancy. It holds no known active operations, website, or public financial disclosures. Investment in this company carries extreme risk, and it should only be considered for speculative or corporate restructuring purposes with full awareness of the near-total loss risk.
Pros
Cons
Business Segments
Content Development & Media
Development of films, music, programs, news serials, documentary films, and software; media production and content creation.
Import/Export & Trading
Manufacturing, dealing, importing, exporting, and commission agency activities.
Revenue Model
Buy Right Impex Limited's stated business involves import-export trading and publishing. Given the negligible share price, the company appears to generate little to no active revenue. Historical operations likely involved trade in published materials or related goods, but current activity is unclear from public sources.
Detailed Analysis
Growth Plans
Potential use for reverse merger or corporate restructuring
Change in management or promoters injecting new business activity
Any announcement of new business vertical or asset injection
Industry Tailwinds
Potential use for reverse merger or corporate restructuring
Recent Developments
The company shows no significant recent operational or corporate developments. Share price remains at ₹0.05, suggesting continued dormancy.
2024-01Comparable Companies
Unlisted
Frequently Asked Questions
About Buy Right Impex
Buy Right Impex Limited is a New Delhi-based company incorporated in 1983 under the Companies Act (CIN: L22100DL1983PLC314401). The company is registered in Paharganj — one of Delhi's most commercially dense areas near New Delhi Railway Station, historically known for its wholesale markets, budget hospitality, and import-export trading activity. The NIC code 22100 relates to publishing activities, though the 'Impex' in the company name suggests import-export trading is also a core function. Paharganj has historically served as a hub for small wholesale traders, importers, and distributors who cater to both domestic retailers and foreign buyers visiting India. Companies registered in this area often engage in multi-category trading of consumer goods, stationery, books, printed materials, and various imported items. The publishing classification (NIC 22100) may reflect original incorporation intent around printed materials or publishing, with subsequent expansion into broader impex activities. The company has key personnel including Neha Aggarwal and other directors per MCA filings. With the 'L' prefix in its CIN, the company was originally intended to be listed or has the public limited structure, though it is effectively unlisted and trades only in secondary OTC markets. At 40+ years of age since its 1983 incorporation, Buy Right Impex represents a legacy trading entity from Delhi's pre-liberalisation commercial era. Such entities often survived by adapting to changing trade dynamics — shifting from specific product niches to broader import-export as India opened its economy in the 1990s and integrated into global supply chains. Specific financial details are limited in public disclosures for this unlisted company.
Key Milestones
Incorporated March 16, 1983 in Delhi (CIN: L22100DL1983PLC314401) as Buckingham Industries Limited
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Change in management or promoters injecting new business activity
Any announcement of new business vertical or asset injection
Industry Headwinds
Continued dormancy leading to NCLT striking off or deregistration
SEBI or MCA action on shell companies
No foreseeable revenue generation path
No financial data available — current operational scale and profitability unknown
Source: AlphaHub Research
Small-scale operation with limited public information
Source: Media Reports / Public Records
The near-zero share price strongly suggests the company is dormant or has ceased active operations, posing a total loss risk for investors.
SEBI and MCA have taken action against shell companies; Buy Right Impex's profile may attract regulatory scrutiny.
There is virtually no active market for shares at ₹0.05. Exiting any position would be extremely difficult.
No public financial statements or annual reports are accessible, making any fundamental analysis impossible.
Publishing and traditional import-export activities have been structurally disrupted; any legacy business may no longer be viable.
Renamed Buy Right Impex Limited; listed on MSEI and Calcutta Stock Exchange
Authorized ₹20 Cr, paid-up ₹16.41 Cr; registered at 38 G/F Rani Jhansi Road, Paharganj, Delhi 110055
Active website: buyrightimpex.in; content development, media, and trading activities
Be the first to discuss Buy Right Impex — share your research, ask questions, or compare notes with other investors.